EVS Glaucoma Therapeutics' Seed VC Round

EVS Glaucoma Therapeutics raised a round of funding on September 11, 2013. Investors include CIT GAP Funds.

EVS Glaucoma Therapeutics (EGT) is a Herndon-based spinout of Euclid Vision Systems that will develop a sustained delivery system for glaucoma medication. EGT will develop an implantable, bio-degradab…

Articles about EVS Glaucoma Therapeutics' Seed VC Round: